-
-
FDA approves ONGENTYS® ▼ (opicapone)
-
Posted in Industry News
-
23rd May 2020
-
News from Bial
-
-
Neurodiem, a new digital platform of independent, high-quality scientific content for UK neuro practitioners
-
Posted in Industry News
-
14th May 2020
-
News from Biogen Inc.
-
-
BNA Journal Indexing
-
Posted in Industry News
-
13th May 2020
-
News from the British Neuroscience Association
-
-
First super-resolution image of tiny brain receptor could give scientists a better understanding of Parkinson’s and Alzheimer’s
-
Posted in Industry News,Neurology News
-
16th Apr 2020
-
Academic news from University of Birmingham
-
-
Outstanding! The Children’s Trust celebrates top CQC & Ofsted ratings whilst facing its biggest challenge in its history
-
Posted in Industry News
-
07th Apr 2020
-
News and fundraising appeal from The Children’s Trust
-
-
Healthcare professionals needed for free virtual consultation service
-
Posted in Industry News
-
01st Apr 2020
-
New service to ease short term strain on the NHS – you can volunteer now
-
-
Licence update for BOTOX® increases involvement of MDT
-
Posted in Industry News
-
30th Mar 2020
-
News of BOTOX® licence update
-
-
Fremanezumab – first anti-CGRP preventive therapy approved by NICE
-
Posted in Industry News
-
12th Mar 2020
-
Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)
-
-
Data from Phase III Trial “SPI2” for Treatment of Progressive MS
-
Posted in Industry News
-
11th Mar 2020
-
News from MedDay Pharma